What Ozempic can't fix

Alice Fullwood, an economics writer at The Economist, and Kate Mann, an associate professor at Cornell, dive into the harsh realities of fatphobia in America. They discuss how fat women earn less than their thinner counterparts and face obstacles in promotions. The conversation critiques the societal pressure for weight loss linked to economic and career opportunities. They evaluate the efficacy of weight-loss drugs like Ozempic, revealing that economic success goes beyond mere body transformation and challenges deep-rooted biases in health and employment.